Results 31 to 40 of about 23,834 (214)

Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation

open access: yesThe Journal of Pathology: Clinical Research, 2019
Immunohistochemistry (IHC) for mismatch repair (MMR) proteins is used to identify MMR status: being diffusely positive (intact/retained nuclear staining) or showing loss of nuclear tumour staining (MMR protein deficient). Four colonic adenocarcinomas and
Aoife J McCarthy   +8 more
doaj   +1 more source

Two-Antibody Staining Method, A Cost-Saving Strategy for Universal Lynch Syndrome Screening in Endometrial Cancers

open access: yesSiriraj Medical Journal, 2022
Objective: Lynch syndrome is an autosomal dominant disorder that increases the risk of cancers in many sites. In women, endometrial cancer is often a sentinel tumor and thus immunohistochemistry for mismatch repair (MMR) proteins MLH1, MSH2, MSH6 and ...
Natthakrit Anansitthikorn   +1 more
doaj   +1 more source

Multiple functions for the N-terminal region of Msh6 [PDF]

open access: yesNucleic Acids Research, 2007
The eukaryotic mismatch repair protein Msh6 shares five domains in common with other MutS members. However, it also contains several hundred additional residues at its N-terminus. A few of these residues bind to PCNA, but the functions of the other amino acids in the N-terminal region (NTR) are unknown.
Clark, Alan B.   +3 more
openaire   +2 more sources

MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer

open access: yesHereditary Cancer in Clinical Practice, 2010
Background Approximately 10% of Lynch syndrome families have a mutation in MSH6 and fewer families have a mutation in PMS2. It is assumed that the cancer incidence is the same in families with mutations in MSH6 as in families with mutations in MLH1/MSH2 ...
Talseth-Palmer Bente A   +4 more
doaj   +1 more source

Generation of homozygous Msh6 mutant ESC lines.

open access: yes, 2013
Sequence analysis of (A) Msh6+/+, Msh6PR/+ and Msh6PR/PR genomic DNA, (B) Msh6+/+, Msh6RH/+ and Msh6RH/RH genomic DNA and (C) Msh6+/+, Msh6LQ/+ and Msh6LQ/LQ genomic DNA. Single letter amino acid codes are given below the sequence. (D) Whole cell lysates
Gözde Isik (397496)   +3 more
core   +1 more source

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer

open access: yesAsian Journal of Urology, 2016
Objective: Although the utility of immunohistochemistry (IHC) for assessing mismatch repair (MMR) protein expression has been demonstrated in solid tumors including primary prostate cancer (PCa), its utility has not been assessed in castration-resistant ...
Belinda Nghiem   +8 more
doaj   +1 more source

Mlh2 is an accessory factor for DNA mismatch repair in Saccharomyces cerevisiae. [PDF]

open access: yesPLoS Genetics, 2014
In Saccharomyces cerevisiae, the essential mismatch repair (MMR) endonuclease Mlh1-Pms1 forms foci promoted by Msh2-Msh6 or Msh2-Msh3 in response to mispaired bases. Here we analyzed the Mlh1-Mlh2 complex, whose role in MMR has been unclear.
Christopher S Campbell   +7 more
doaj   +1 more source

DNA methylation of selected tumor suppressor genes in endometrial hyperplasia

open access: yesBiomedical Papers
Aims. To investigate DNA methylation of specific gene promoters in endometrial hyperplasia compared to normal endometrial tissue. Materials and Methods.
Ondrej Dvorak   +4 more
doaj   +1 more source

Association between colorectal cancer, the frequency of Bacteroides fragilis, and the level of mismatch repair genes expression in the biopsy samples of Iranian patients

open access: yesBMC Gastroenterology
Background Deficient DNA mismatch repair (MMR) can cause microsatellite instability (MSI) and is more common in colorectal cancer (CRC) patients.
Nooshin Nazarinejad   +7 more
doaj   +1 more source

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia

open access: yesHaematologica, 2018
Survival of children with relapsed acute lymphoblastic leukemia is poor, and understanding mechanisms underlying resistance is essential to developing new therapy.
Nikki A. Evensen   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy